EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma

Fergal G Kavanagh iD, Alana Eagan, Lillian A Boe, Sean M McBride, Nancy Y Lee, Marc A Cohen iD, Jennifer R Cracchiolo iD

Journal of Surgical Oncology · 2026

DOI: 10.1002/jso.70327 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Fergal G Kavanagh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Mouth Neoplasms, Neoplasm Staging, Practice Guidelines as Topic, Carcinoma, Squamous Cell. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In 2018, the American Joint Committee on Cancer (AJCC) updated TNM (Tumor, Nodes, Metastasis) staging for oral cavity cancers, incorporating depth of invasion into T‐staging, but the impact of this change is unclear. We aimed to assess trends in upstaging and adjuvant radiation therapy use among patients with T1‐3 oral cavity tumors using the National Cancer Database (NCDB).

Methods

NCDB data were analyzed on the staging and treatment of patients with T1‐3 histologically confirmed squamous cell carcinoma of the oral cavity treated with surgery from 2013 to 2021. Treatment periods were defined as 2013–2017 and 2018–2021 to reflect use of the 7th and 8th editions of the AJCC staging system. Trends were analyzed using Cochran‐Armitage tests, univariable/multivariable logistic regression, and Kaplan‐Meier survival plots, and adjusted for sociodemographic, tumor, and hospital variables when relevant. The primary outcome was treatment modality (surgery alone vs. surgery with adjuvant therapy). The secondary outcome was change in tumor staging following the AJCC revision.

Results

We analyzed NCDB data on the staging and treatment of 17,349 patients. The proportion of patients with pathological T1 tumors dropped from 42% to 29% between 2013 and 2017 and 2018–2021, while T3 cases rose from 5.5% to 15% ( p < 0.001). The proportion of stage I tumors decreased from 26% to 17%, and stage III tumors increased from 10% to 15% ( p < 0.001). Tumor size remained relatively stable. The proportion of patients treated with surgery and adjuvant radiation therapy increased from 29% to 34% ( p < 0.001). The increased use of adjuvant radiation after the AJCC revision was confirmed by the Cochran‐Armitage test and by multivariable logistic regression, which showed that patients diagnosed in 2018–2021 had higher odds of receiving radiation therapy (odds ratio, 1.33; p < 0.001) than those diagnosed in 2013–2017, after adjustment for covariates. Forty‐eight‐month overall survival did not differ between cohorts (64% in both groups).

Conclusion

Although the 2018 AJCC revision for oral cavity cancer staging led to significant upstaging and increased use of adjuvant radiation therapy, overall survival remained unchanged. The benefits of increased adjuvant therapy use remain unclear and warrant further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsNeoplasm StagingPractice Guidelines as TopicCarcinoma, Squamous CellSquamous Cell Carcinoma of Head and NeckHumansFemaleRadiotherapy, AdjuvantMaleMiddle AgedAgedUnited StatesSurvival Rate

Stichwörter der Autor:innen

AJCC 8th EditionNational Cancer Database (NCDB)adjuvant radiation therapydepth of invasion (DOI)oral cavity squamous cell carcinomasurvival outcomesupstaging

Autor:innen und Institutionen

  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Fergal G Kavanagh, Marc A Cohen, Jennifer R Cracchiolo

Förderung

  • NCI NIH HHS

Zitieren

APA

Kavanagh, F. G., Eagan, A., Boe, L. A., McBride, S. M., Lee, N. Y., Cohen, M. A., & Cracchiolo, J. R. (2026). Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70327

Vancouver

Kavanagh FG, Eagan A, Boe LA, McBride SM, Lee NY, Cohen MA, et al. Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70327

BibTeX
@article{Kavanagh2026,
  author = {Kavanagh, Fergal G and Eagan, Alana and Boe, Lillian A and McBride, Sean M and Lee, Nancy Y and Cohen, Marc A and Cracchiolo, Jennifer R},
  title = {Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70327}
}
Kostenlos starten →